FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:816-819 March 24, 1994 Number 12 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background In cardiac transplantation, it is standard practice for donor hearts to be allocated to recipients without consideration of the extent of HLA matching. Because the HLA system is highly polymorphic, the likelihood that donor hearts will be well matched to their recipients by chance alone is extremely small. It has therefore not been possible in the past to analyze adequately the success rate of transplantation with HLA-matched hearts.

Methods We initiated a collaborative study in 1985 to evaluate the influence of HLA compatibility on graft survival in heart transplantation. Data were collected from 104 centers in 24 countries.

Results Of the 8331 patients, 128 received a graft with no HLA-A, B, or DR mismatches or only one mismatch. This frequency (1.5 percent) corresponds to the rate that would be expected from a random allocation of donor organs. The three-year rate of graft survival correlated strongly with HLA compatibility, decreasing from a mean (±SE) of 83 ±4 percent for the 128 donor hearts with no mismatches or only one mismatch to 76 ±2 percent for the 439 hearts with two mismatches and 71 ±1 percent for the 7764 hearts with three to six mismatches (P<0.001). Multifactorial Cox regression analysis showed that this effect was independent of the age and sex of the donor and recipient, the type of underlying disease, the duration of cold ischemia, and the use of prophylaxis with antilymphocyte antibodies (P = 0.005).

Conclusions Graft survival in heart transplantation is significantly influenced by the extent of HLA compatibility.

Source Information

From the Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Heidelberg, Germany. Supported in part by grants from Deutsche Stiftung Organtransplantation and Deutsche Krebshilfe.

Address reprint requests to Dr. Opelz at the Institute of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, D-69120 Heidelberg, Germany.

Full Text of this Article

Related Letters:

HLA Compatibility and Graft Survival after Heart Transplantation
Hauptman P. J., Vereerstraeten P., Abramowicz D., Andrien M., Opelz G., Wujciak T.
Extract | Full Text  
N Engl J Med 1994; 331:404-405, Aug 11, 1994. Correspondence

This article has been cited by other articles:

• Griffith, B. P., Haddad, M., Poston, R. S. (2008). Immunobiology of Heart and Heart-Lung Transplantation. Card Surg Adult 3: 1513-1538 [Full Text]  
• Bruschi, G., Busnach, G., Colombo, T., Radaelli, L., Pedrazzini, G., Garatti, A., Sansalone, C. V., Frigerio, M., Vitali, E. (2007). Long-Term Follow-Up of Simultaneous Heart and Kidney Transplantation With Single Donor Allografts: Report of Nine Cases. Ann. Thorac. Surg. 84: 522-527 [Abstract] [Full Text]  
• Jacobs, J. P., Quintessenza, J. A., Boucek, R. J., Morell, V. O., Botero, L. M., Badhwar, V., van Gelder, H. M., Asante-Korang, A., McCormack, J., Daicoff, G. R. (2004). Pediatric Cardiac Transplantation in Children With High Panel Reactive Antibody. Ann. Thorac. Surg. 78: 1703-1709 [Abstract] [Full Text]  
• Poston, R. S., Gu, J., Prastein, D., Gage, F., Hoffman, J. W., Kwon, M., Azimzadeh, A., Pierson, R. N. III, Griffith, B. P. (2004). Optimizing Donor Heart Outcome After Prolonged Storage With Endothelial Function Analysis and Continuous Perfusion. Ann. Thorac. Surg. 78: 1362-1370 [Abstract] [Full Text]  
• Poston, R. S., Griffith, B. P. (2004). Heart Transplantation. J Intensive Care Med 19: 3-12 [Abstract]  
• Trachiotis, G. D., Vega, J. D., Johnston, T. S., Berg, A., Whelchel, J., Smith, A. L., Lutz, J., Kanter, K. R. (2003). Ten-year follow-up in patients with combined heart and kidney transplantation. J. Thorac. Cardiovasc. Surg. 126: 2065-2071 [Abstract] [Full Text]  
• Vassalli, G., Gallino, A., Weis, M., von Scheidt, W., Kappenberger, L., von Segesser, L.K., Goy, J.-J., on behalf of the Working Group Microcirculation of, (2003). Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 24: 1180-1188 [Abstract] [Full Text]  
• Griffith, B. P., Poston, R. S. (2003). Immunobiology of Heart and Heart-Lung Transplantation. Card Surg Adult 2: 1403-1426 [Full Text]  
• Petersdorf, E. W., Hansen, J. A., Martin, P. J., Woolfrey, A., Malkki, M., Gooley, T., Storer, B., Mickelson, E., Smith, A., Anasetti, C. (2001). Major-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation. NEJM 345: 1794-1800 [Abstract] [Full Text]  
• Stoica, S. C., Satchithananda, D. K., Dunning, J., Large, S. R. (2001). Two-decade analysis of cardiac storage for transplantation. Eur. J. Cardiothorac. Surg. 20: 792-798 [Abstract] [Full Text]  
• WALDOCK, A, COOK, S D (2000). Corneal transplantation: how successful are we?. Br. J. Ophthalmol. 84: 813-815 [Full Text]  
• Wang, C. Y., Aronson, I., Takuma, S., Homma, S., Naka, Y., Alshafie, T., Brovkovych, V., Malinski, T., Oz, M. C., Pinsky, D. J. (2000). cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy. Circ. Res. 86: 982-988 [Abstract] [Full Text]  
• Gammie, J. S., Stukus, D. R., Pham, S. M., Hattler, B. G., McGrath, M. F., McCurry, K. R., Griffith, B. P., Keenan, R. J. (1999). Effect of ischemic time on survival in clinical lung transplantation. Ann. Thorac. Surg. 68: 2015-2019 [Abstract] [Full Text]  
• Simon, A., Wilhelmi, M., Steinhoff, G., Harringer, W., Brucke, P., Haverich, A. (1998). CARDIAC VALVE ENDOTHELIAL CELLS: RELEVANCE IN THE LONG-TERM FUNCTION OF BIOLOGIC VALVE PROSTHESES. J. Thorac. Cardiovasc. Surg. 116: 609-616 [Abstract] [Full Text]  
• SCHULMAN, L. L., WEINBERG, A. D., MCGREGOR, C., GALANTOWICZ, M. E., SUCIU-FOCA, N. M., ITESCU, S. (1998). Mismatches at the HLA-DR and HLA-B Loci Are Risk Factors for Acute Rejection after Lung Transplantation. Am. J. Respir. Crit. Care Med. 157: 1833-1837 [Abstract] [Full Text]  
• Hauptman, P. J., O'Connor, K. J. (1997). Procurement and Allocation of Solid Organs for Transplantation. NEJM 336: 422-431 [Full Text]  
• Petersdorf, E. W., Longton, G. M., Anasetti, C., Mickelson, E. M., Smith, A. G., Martin, P. J., Hansen, J. A. (1996). Definition of HLA-DQ as a transplantation antigen. Proc. Natl. Acad. Sci. USA 93: 15358-15363 [Abstract] [Full Text]  
• Hosenpud, J. D., Edwards, E. B., Lin, H.-M., Daily, O. P. (1996). Influence of HLA Matching on Thoracic Transplant Outcomes: An Analysis From the UNOS/ISHLT* Thoracic Registry. Circulation 94: 170-174 [Abstract] [Full Text]  
• Fyfe, B., Loh, E., Winters, G. L., Couper, G. S., Kartashov, A. I., Schoen, F. J. (1996). Heart Transplantation–Associated Perioperative Ischemic Myocardial Injury : Morphological Features and Clinical Significance. Circulation 93: 1133-1140 [Abstract] [Full Text]  
• Oz, M. C., Liao, H., Naka, Y., Seldomridge, A., Becker, D. N., Michler, R. E., Smith, C. R., Rose, E. A., Stern, D. M., Pinsky, D. J. (1995). Ischemia-Induced Interleukin-8 Release After Human Heart Transplantation : A Potential Role for Endothelial Cells. Circulation 92: 428-432 [Abstract] [Full Text]  
• Drinkwater, D. C. Jr., Ziv, E. T., Laks, H., Lee, J. R., Bhuta, S., Rudis, E., Chang, P. (1995). Extracellular and standard University of Wisconsin solutions provide equivalent preservation of myocardial function. J. Thorac. Cardiovasc. Surg. 110: 738-745 [Abstract] [Full Text]  
• Hauptman, P. J., Vereerstraeten, P., Abramowicz, D., Andrien, M., Opelz, G., Wujciak, T. (1994). HLA Compatibility and Graft Survival after Heart Transplantation. NEJM 331: 404-405 [Full Text]  
• Morris, P. J. (1994). HLA Matching and Cardiac Transplantation. NEJM 330: 857-858 [Full Text]